5WA.SI - OUE Lippo Healthcare Limited

SES - SES Delayed Price. Currency in SGD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2018
31/12/2017
31/12/2016
Total revenue
19,172
19,563
43,571
49,060
Cost of revenue
5,066
5,475
24,976
26,218
Gross profit
14,106
14,088
18,595
22,842
Operating expenses
Research development
-
-
-
-
Selling general and administrative
15,253
16,440
18,321
13,386
Total operating expenses
13,635
16,384
18,321
16,709
Operating income or loss
471
-2,296
274
6,133
Interest expense
7,276
10,133
15,885
27,299
Total other income/expenses net
-
-
-
-
Income before tax
5,049
-7,540
-81,765
-75,816
Income tax expense
3,184
1,246
8,223
1,051
Income from continuing operations
1,865
-8,786
-89,988
-76,867
Net income
1,865
-9,318
-90,700
-76,847
Net income available to common shareholders
1,865
-9,318
-90,700
-76,847
Reported EPS
Basic
-
-0.00
-0.05
-0.04
Diluted
-
-0.00
-0.05
-0.04
Weighted average shares outstanding
Basic
-
2,614,788
1,896,074
1,896,074
Diluted
-
2,614,788
1,896,074
1,896,074
EBITDA
-
4,511
-63,813
-47,116